Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Minority Interest: 2020-2024

Historic Minority Interest for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Dec 2024 value amounting to $251.9 million.

  • Maravai Lifesciences Holdings' Minority Interest fell 30.39% to $186.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $186.4 million, marking a year-over-year decrease of 30.39%. This contributed to the annual value of $251.9 million for FY2024, which is 32.49% down from last year.
  • According to the latest figures from FY2024, Maravai Lifesciences Holdings' Minority Interest is $251.9 million, which was down 32.49% from $373.1 million recorded in FY2023.
  • In the past 5 years, Maravai Lifesciences Holdings' Minority Interest ranged from a high of $373.1 million in FY2023 and a low of $66.2 million during FY2020.
  • For the 3-year period, Maravai Lifesciences Holdings' Minority Interest averaged around $328.4 million, with its median value being $360.0 million (2022).
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Minority Interest soared by 247.04% in 2021 and then slumped by 32.49% in 2024.
  • Yearly analysis of 5 years shows Maravai Lifesciences Holdings' Minority Interest stood at $66.2 million in 2020, then spiked by 247.04% to $229.9 million in 2021, then skyrocketed by 56.63% to $360.0 million in 2022, then climbed by 3.64% to $373.1 million in 2023, then slumped by 32.49% to $251.9 million in 2024.